5 Key Takeaways

• 1

  Biotech boards are increasingly prioritizing leaders whose experience matches the company’s next milestones over résumé recognition or broad industry stature.

• 2

  Companies seek adaptable executives who have broadened their expertise and can navigate changing markets, regulations, financing conditions, and scientific advances.

• 3

  Chief business officers increasingly translate strategy into transactions, using market intelligence and pattern recognition to assess partnerships and deal structures.

• 4

  Effective boards combine complementary scientific, capital markets, regulatory, operational, commercialization, and transaction expertise, while planning for future capability gaps.

• 5

  Overreliance on existing networks can narrow candidate pools and limit diversity of perspective, making broader searches important for executive and board hiring.